Haemonetics Corporation
NYSE HAE · Boston, MA
Haemonetics Corporation is a clinical trial sponsor based in Boston, MA, listed as NYSE HAE. It has no active clinical trials as lead sponsor. Since 2021 it has completed 5 trials and stopped 0 early.
Trial track record · since 2021
Financials · NYSE HAE
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
Questions about Haemonetics Corporation
Haemonetics Corporation has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 5 trials and stopped 0 early.
Haemonetics Corporation is based in Boston, MA and is listed as NYSE HAE. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Haemonetics Corporation; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2024-04-08.
Approve Suite is not affiliated with Haemonetics Corporation. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.